Stock PRN PROFOUND MEDICAL CORP
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Official Publications Profound Medical Corp Toronto S.E.

Equities

PRN

CA74319B1067

End-of-day quote Toronto S.E.
Other stock markets
- CAD - Intraday chart for Profound Medical Corp
May. 06 Profound Medical Says Clinical Evidence Points to Potential of Its TULSA Procedure as a Treatment for Prostate Cancer MT
May. 06 Profound Medical Brief: Adds Clinical evidence Continues to highlight TULSA's "Ability to treat an unrivalled variety of patients with localized prostate cancer and/or BPH" MT

Official Publications

No official publication found

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies
  1. Stock Market
  2. Equities
  3. PRN Stock
  4. PRN Stock
  5. News Profound Medical Corp
  6. Official Publications
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW